Genetic and Rare Diseases Information Center (GARD)


Other names people use for this condition
  • JNCL
  • Ceroid lipofuscinosis, neuronal 3
  • CLN3
  • Batten disease
  • Vogt Spielmeyer disease
  • Spielmeyer-Vogt-Sjogren-Batten disease

Juvenile neuronal ceroid lipofuscinosis
Please note that the links contained on this search results page may take you to sites outside of the NIH. (See Disclaimer under Site Policies for details.)


Juvenile neuronal ceroid lipofuscinosis (JNCL) is a neurodegenerative genetic condition characterized by progressive mental and motor deterioration, seizures, and early death. Symptoms of JNCL typically appear between the ages of four and ten years. Rapid vision loss resulting in total blindness is usually the first symptom observed. Followed by seizures which typically present between ages five and 18 years. Life expectancy generally ranges from the late teens to the 30's. JNCL is inherited in an autosomal recessive fashion and has been associated with mutations in a gene called the CLN3.  Although a cure has not been identified for JNCL, treatment for the symptoms is available.[1]

References
  1. Wisniewski KE. Neuronal Ceroid-Lipofuscinoses. GeneReviews. May 17, 2006 Available at: http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ncl. Accessed January 12, 2009.

For more information about Juvenile neuronal ceroid lipofuscinosis click on the boxes below:
Q&A More Detailed
Information
Support
Groups
Clinical Trials &
Research
Services NLM Gateway

Questions & Answers
If you would like to submit a question Contact GARD

   Click arrows to expand or collapse a Resource Section.
   Show All Resources   Hide All Resources




Note: If you need help accessing information in different file formats such as PDF, MP3, see Viewers, Players, and Plug-ins.